BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $328,000 | -77.6% | 2,364 | -84.3% | 0.02% | -77.5% |
| Q2 2021 | $1,466,000 | +431.2% | 15,099 | +255.0% | 0.08% | +110.5% |
| Q3 2020 | $276,000 | -58.0% | 4,253 | -52.7% | 0.04% | -64.5% |
| Q2 2020 | $657,000 | -7.7% | 8,984 | -47.4% | 0.11% | -0.9% |
| Q3 2019 | $712,000 | +101.1% | 17,064 | +110.8% | 0.11% | +129.8% |
| Q2 2019 | $354,000 | -68.0% | 8,094 | -62.3% | 0.05% | -69.7% |
| Q1 2019 | $1,106,000 | +261.4% | 21,484 | +159.4% | 0.16% | +171.9% |
| Q4 2018 | $306,000 | – | 8,282 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |